The Greater Cannabis Company, Inc. (GCAN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0001 (-20.00%)
Aug 22, 2025, 12:51 PM EDT
GCAN Market Cap
GCAN has a market cap or net worth of $269.98 thousand as of August 22, 2025. Its market cap has decreased by -44.08% in one year.
Market Cap
269.98K
Enterprise Value
526.54K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 18, 2018, GCAN's market cap has decreased from 4.11M to 269.98K, a decrease of -93.44%. That is a compound annual growth rate of -32.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 269.98K | -16.12% |
| Dec 31, 2024 | 321.86K | -51.31% |
| Dec 29, 2023 | 661.03K | 64.05% |
| Dec 30, 2022 | 402.95K | -74.44% |
| Dec 31, 2021 | 1.58M | 13.07% |
| Dec 31, 2020 | 1.39M | 13.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |